IP Verse

Currax Pharmaceuticals Llc V. Taro Pharmaceutical Industries Limited - 7:24-cv-05040

Explore the details of the Currax Pharmaceuticals Llc V. Taro Pharmaceutical Industries Limited case under case number 7:24-cv-05040 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
7:24-cv-05040
Filing Date
Jul 2, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Taro Pharmaceuticals Inc. -
Currax Pharmaceuticals LLC -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 2, 2024COMPLAINT against Taro Pharmaceutical Industries Limited, Taro Pharmaceuticals Inc., Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 405.00, Receipt Number ANYSDC-29561440)Document filed by Currax Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - '307 patent, # 2 Exhibit B - '299 patent, # 3 Exhibit C - '898 patent, # 4 Exhibit D - '437 patent, # 5 Exhibit E - '814 patent, # 6 Exhibit F - '607 patent, # 7 Exhibit G - '620 patent, # 8 Exhibit H - '660 patent, # 9 Exhibit I - '662 patent, # 10 Exhibit J - '074 patent).(Garrett, Zachary) (Entered: 07/02/2024)Attachment
Jul 2, 2024COMPLAINT against Taro Pharmaceutical Industries Limited, Taro Pharmaceuticals Inc., Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 405.00, Receipt Number ANYSDC-29561440)Document filed by Currax Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - '307 patent, # 2 Exhibit B - '299 patent, # 3 Exhibit C - '898 patent, # 4 Exhibit D - '437 patent, # 5 Exhibit E - '814 patent, # 6 Exhibit F - '607 patent, # 7 Exhibit G - '620 patent, # 8 Exhibit H - '660 patent, # 9 Exhibit I - '662 patent, # 10 Exhibit J - '074 patent).(Garrett, Zachary) (Entered: 07/02/2024)Attachment
Jul 2, 2024COMPLAINT against Taro Pharmaceutical Industries Limited, Taro Pharmaceuticals Inc., Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 405.00, Receipt Number ANYSDC-29561440)Document filed by Currax Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - '307 patent, # 2 Exhibit B - '299 patent, # 3 Exhibit C - '898 patent, # 4 Exhibit D - '437 patent, # 5 Exhibit E - '814 patent, # 6 Exhibit F - '607 patent, # 7 Exhibit G - '620 patent, # 8 Exhibit H - '660 patent, # 9 Exhibit I - '662 patent, # 10 Exhibit J - '074 patent).(Garrett, Zachary) (Entered: 07/02/2024)Attachment
Jul 2, 2024COMPLAINT against Taro Pharmaceutical Industries Limited, Taro Pharmaceuticals Inc., Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 405.00, Receipt Number ANYSDC-29561440)Document filed by Currax Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - '307 patent, # 2 Exhibit B - '299 patent, # 3 Exhibit C - '898 patent, # 4 Exhibit D - '437 patent, # 5 Exhibit E - '814 patent, # 6 Exhibit F - '607 patent, # 7 Exhibit G - '620 patent, # 8 Exhibit H - '660 patent, # 9 Exhibit I - '662 patent, # 10 Exhibit J - '074 patent).(Garrett, Zachary) (Entered: 07/02/2024)Attachment
Jul 2, 2024COMPLAINT against Taro Pharmaceutical Industries Limited, Taro Pharmaceuticals Inc., Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 405.00, Receipt Number ANYSDC-29561440)Document filed by Currax Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - '307 patent, # 2 Exhibit B - '299 patent, # 3 Exhibit C - '898 patent, # 4 Exhibit D - '437 patent, # 5 Exhibit E - '814 patent, # 6 Exhibit F - '607 patent, # 7 Exhibit G - '620 patent, # 8 Exhibit H - '660 patent, # 9 Exhibit I - '662 patent, # 10 Exhibit J - '074 patent).(Garrett, Zachary) (Entered: 07/02/2024)Attachment
Jul 2, 2024COMPLAINT against Taro Pharmaceutical Industries Limited, Taro Pharmaceuticals Inc., Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 405.00, Receipt Number ANYSDC-29561440)Document filed by Currax Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - '307 patent, # 2 Exhibit B - '299 patent, # 3 Exhibit C - '898 patent, # 4 Exhibit D - '437 patent, # 5 Exhibit E - '814 patent, # 6 Exhibit F - '607 patent, # 7 Exhibit G - '620 patent, # 8 Exhibit H - '660 patent, # 9 Exhibit I - '662 patent, # 10 Exhibit J - '074 patent).(Garrett, Zachary) (Entered: 07/02/2024)Attachment
Jul 2, 2024COMPLAINT against Taro Pharmaceutical Industries Limited, Taro Pharmaceuticals Inc., Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 405.00, Receipt Number ANYSDC-29561440)Document filed by Currax Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - '307 patent, # 2 Exhibit B - '299 patent, # 3 Exhibit C - '898 patent, # 4 Exhibit D - '437 patent, # 5 Exhibit E - '814 patent, # 6 Exhibit F - '607 patent, # 7 Exhibit G - '620 patent, # 8 Exhibit H - '660 patent, # 9 Exhibit I - '662 patent, # 10 Exhibit J - '074 patent).(Garrett, Zachary) (Entered: 07/02/2024)Attachment
Jul 2, 2024COMPLAINT against Taro Pharmaceutical Industries Limited, Taro Pharmaceuticals Inc., Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 405.00, Receipt Number ANYSDC-29561440)Document filed by Currax Pharmaceuticals LLC. (Attachments: # 1 Exhibit A - '307 patent, # 2 Exhibit B - '299 patent, # 3 Exhibit C - '898 patent, # 4 Exhibit D - '437 patent, # 5 Exhibit E - '814 patent, # 6 Exhibit F - '607 patent, # 7 Exhibit G - '620 patent, # 8 Exhibit H - '660 patent, # 9 Exhibit I - '662 patent, # 10 Exhibit J - '074 patent).(Garrett, Zachary) (Entered: 07/02/2024)Attachment